Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.
|
Nat Med
|
2002
|
7.59
|
2
|
The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.
|
JAMA
|
2005
|
6.49
|
3
|
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.
|
JAMA
|
2005
|
6.14
|
4
|
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.
|
Blood
|
2005
|
3.98
|
5
|
Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality.
|
Ann Intern Med
|
1991
|
2.17
|
6
|
Causes of death in sickle cell disease: an autopsy study.
|
Br J Haematol
|
2003
|
1.96
|
7
|
Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure.
|
J Am Soc Nephrol
|
2006
|
1.94
|
8
|
Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors.
|
Nephrol Dial Transplant
|
2006
|
1.92
|
9
|
Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass.
|
Kidney Int
|
1982
|
1.86
|
10
|
Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme.
|
N Engl J Med
|
1992
|
1.82
|
11
|
Renal myogenic response: kinetic attributes and physiological role.
|
Circ Res
|
2002
|
1.74
|
12
|
Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes.
|
J Am Soc Nephrol
|
2006
|
1.35
|
13
|
Estimating glomerular filtration rate in black South Africans by use of the modification of diet in renal disease and Cockcroft-Gault equations.
|
Clin Chem
|
2008
|
1.31
|
14
|
A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia.
|
Am J Med
|
1998
|
1.16
|
15
|
Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration.
|
Diabetes
|
2000
|
1.12
|
16
|
Prevalence of microalbuminuria in children with sickle cell disease.
|
Pediatr Nephrol
|
1998
|
1.10
|
17
|
Elderly survivors with homozygous sickle cell disease.
|
N Engl J Med
|
2007
|
1.07
|
18
|
Enalapril reduces the albuminuria of patients with sickle cell disease.
|
Am J Med
|
1995
|
0.95
|
19
|
[Guidelines for management of adult sickle cell disease].
|
Rev Med Interne
|
2009
|
0.94
|
20
|
Glomerular hyperfiltration in microalbuminuric NIDDM patients.
|
Diabetologia
|
1996
|
0.91
|
21
|
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.
|
Vasc Health Risk Manag
|
2009
|
0.90
|
22
|
51Cr-EDTA measurements of the glomerular filtration rate in patients with sickle cell anaemia and minor renal damage.
|
Nucl Med Commun
|
2006
|
0.90
|
23
|
Comparison of renal function markers in Kuwaiti patients with sickle cell disease.
|
J Clin Pathol
|
2006
|
0.88
|
24
|
Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis.
|
Am J Hematol
|
2008
|
0.87
|